Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.71NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.71NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBC.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.213NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.213NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.56 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.56 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.39.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.91.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.91.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.4.14 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.14 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.359NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.359NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.36.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.23NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.134NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.134NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.39.1.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.39.1.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.3.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.38NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-4360.53China
BN.1.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.66NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.66NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.485NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.485NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.73NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.73NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.112.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.112.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Q.8 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.8 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.122.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.122.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.5.6 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.5.6 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used